Clinical Trial Update: Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating tadalafil for severe pulmonary hypertension caused by chronic obstructive pulmonary disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Pulmonary Hypertension, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: RECRUITING